(Q36458753)

14 August 2017

1 reference

title

Complementary and alternative medicine: is there a role in multiple sclerosis? (English)

1 reference

14 August 2017

0 references

Vijayshree Yadav

1

1 reference

PubMed ID

16635436

14 August 2017

Dennis Bourdette

series ordinal

2

1 reference

14 August 2017

1 May 2006

1 reference

Current Neurology and Neuroscience Reports

14 August 2017

1 reference

14 August 2017

6

1 reference

14 August 2017

3

1 reference

14 August 2017

259-267

1 reference

https://scigraph.springernature.com/pub.10.1007/s11910-006-0014-y

14 August 2017

0 references

cites work

Omega-3 fatty acids in inflammation and autoimmune diseases

1 reference

https://api.crossref.org/works/10.1007%2FS11910-006-0014-Y

The pharmacology of the antioxidant lipoic acid

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11910-006-0014-Y

Intakes of carotenoids, vitamin C, and vitamin E and MS risk among two large cohorts of women

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11910-006-0014-Y

Attenuation of experimental autoimmune encephalomyelitis and nonimmune demyelination by IFN-beta plus vitamin B12: treatment to modify notch-1/sonic hedgehog balance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11910-006-0014-Y

Fracture history and bone loss in patients with MS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11910-006-0014-Y

Vitamin D intake and incidence of multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11910-006-0014-Y

Exercise and rehabilitation for individuals with multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11910-006-0014-Y

Randomized controlled trial of yoga and exercise in multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11910-006-0014-Y

The effect of cannabis on tremor in patients with multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11910-006-0014-Y

Apomorphine-induced eosinophilic panniculitis and hypereosinophilia in Parkinson disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11910-006-0014-Y

Low fat dietary intervention with omega-3 fatty acid supplementation in multiple sclerosis patients.

21 January 2018

1 reference

12 December 2020

Efficacy, safety and tolerability of an orally administered cannabis extract in the treatment of spasticity in patients with multiple sclerosis: a randomized, double-blind, placebo-controlled, crossover study

1 reference

12 December 2020

Multiple sclerosis and nutrition

1 reference

12 December 2020

Nutritional factors in the aetiology of multiple sclerosis: a case-control study in Montreal, Canada

1 reference

12 December 2020

Alpha-lipoic acid in the treatment of diabetic polyneuropathy in Germany: current evidence from clinical trials

1 reference

12 December 2020

Mounting evidence for vitamin D as an environmental factor affecting autoimmune disease prevalence.

1 reference

12 December 2020

Alpha lipoic acid inhibits T cell migration into the spinal cord and suppresses and treats experimental autoimmune encephalomyelitis

1 reference

12 December 2020

Antioxidants and polyunsaturated fatty acids in multiple sclerosis

1 reference

12 December 2020

A randomized crossover study of bee sting therapy for multiple sclerosis.

1 reference

12 December 2020

Alpha-lipoic acid is effective in prevention and treatment of experimental autoimmune encephalomyelitis.

1 reference

12 December 2020

Do cannabis-based medicinal extracts have general or specific effects on symptoms in multiple sclerosis? A double-blind, randomized, placebo-controlled study on 160 patients

1 reference

12 December 2020

Complementary and Alternative Therapy Use in Persons with Multiple Sclerosis

1 reference

12 December 2020

Cannabinoids in multiple sclerosis (CAMS) study: safety and efficacy data for 12 months follow up.

1 reference

12 December 2020

Gene expression analysis suggests that 1,25-dihydroxyvitamin D3 reverses experimental autoimmune encephalomyelitis by stimulating inflammatory cell apoptosis

1 reference

12 December 2020

1,25-Dihydroxyvitamin D3 reversibly blocks the progression of relapsing encephalomyelitis, a model of multiple sclerosis

1 reference

12 December 2020

Can the cognitive enhancing effects of ginkgo biloba be explained by its pharmacology?

1 reference

12 December 2020

Marijuana and multiple sclerosis

1 reference

12 December 2020

Use of unconventional therapies by individuals with multiple sclerosis

1 reference

12 December 2020

Treatment of symptomatic diabetic polyneuropathy with the antioxidant alpha-lipoic acid: a 7-month multicenter randomized controlled trial (ALADIN III Study). ALADIN III Study Group. Alpha-Lipoic Acid in Diabetic Neuropathy

1 reference

12 December 2020

A randomised placebo controlled exploratory study of vitamin B-12, lofepramine, and L-phenylalanine (the "Cari Loder regime") in the treatment of multiple sclerosis.

1 reference

12 December 2020

Intracellular oxidative activity and respiratory burst of leukocytes isolated from multiple sclerosis patients

1 reference

12 December 2020

Terpene trilactones from Ginkgo biloba are antagonists of cortical glycine and GABA(A) receptors

1 reference

12 December 2020

Alpha lipoic acid inhibits human T-cell migration: implications for multiple sclerosis

1 reference

12 December 2020

Serum cobalamin deficiency is uncommon in multiple sclerosis

1 reference

12 December 2020

Effects of a 6-month exercise program on patients with multiple sclerosis: a randomized study

1 reference

12 December 2020

Effects of aerobic and strength exercise on motor fatigue in men and women with multiple sclerosis: a randomized controlled trial

1 reference

12 December 2020

Medicinal cannabis extracts for the treatment of multiple sclerosis

1 reference

12 December 2020

Serum levels of antioxidant vitamins and lipid peroxidation in multiple sclerosis

1 reference

12 December 2020

Increased levels of lipid hydroperoxides in plasma of patients with multiple sclerosis: a relationship with paraoxonase activity

1 reference

12 December 2020

A pilot study of the effect of aerobic exercise on people with moderate disability multiple sclerosis

1 reference

12 December 2020

Risk of bone loss in men with multiple sclerosis

1 reference

12 December 2020

Alternative und komplementäre Therapien der Multiplen Sklerose

1 reference

12 December 2020

High prevalence of vitamin D deficiency and reduced bone mass in multiple sclerosis

1 reference

12 December 2020

Preventive healthcare in women with multiple sclerosis

1 reference

12 December 2020

Vitamin B12 metabolism in multiple sclerosis

1 reference

12 December 2020

Lipid peroxidation in experimental spinal cord injury. Comparison of treatment with Ginkgo biloba, TRH and methylprednisolone

1 reference

12 December 2020

Nutrition and diet in the clinical management of multiple sclerosis

1 reference

12 December 2020

Exercise therapy for multiple sclerosis

1 reference

12 December 2020

Towards cannabis and cannabinoid treatment of multiple sclerosis.

1 reference

12 December 2020

A pilot study of oral calcitriol (1,25-dihydroxyvitamin D3) for relapsing-remitting multiple sclerosis

1 reference

12 December 2020

The efficacy of Ginkgo biloba on cognitive function in Alzheimer disease.

1 reference

12 December 2020

Vitamin B12 metabolism and massive-dose methyl vitamin B12 therapy in Japanese patients with multiple sclerosis

1 reference

12 December 2020

Vitamin E and neurodegenerative disorders associated with oxidative stress

1 reference

12 December 2020

Vitamin B12, demyelination, remyelination and repair in multiple sclerosis

1 reference

12 December 2020

Vitamin B12 and its relationship to age of onset of multiple sclerosis

1 reference

12 December 2020

Lipoic acid in multiple sclerosis: a pilot study

1 reference

12 December 2020

Lipoperoxidation induced by hydrogen peroxide in human erythrocyte membranes. 2. Comparison of the antioxidant effect of Ginkgo biloba extract (EGb 761) with those of water-soluble and lipid-soluble antioxidants

1 reference

12 December 2020

Patterns of cannabis use among patients with multiple sclerosis.

1 reference

12 December 2020

Cannabinoids for treatment of spasticity and other symptoms related to multiple sclerosis (CAMS study): multicentre randomised placebo-controlled trial

1 reference

12 December 2020

Double blind placebo controlled multicentre study of ginkgolide B in treatment of acute exacerbations of multiple sclerosis. The Ginkgolide Study Group in multiple sclerosis

1 reference

12 December 2020

The possible role of gradual accumulation of copper, cadmium, lead and iron and gradual depletion of zinc, magnesium, selenium, vitamins B2, B6, D, and E and essential fatty acids in multiple sclerosis

1 reference

12 December 2020

Review of MS patient survival on a Swank low saturated fat diet

1 reference

12 December 2020

Is there a role for saturated and long-chain fatty acids in multiple sclerosis?

1 reference

12 December 2020

Exercise and multiple sclerosis

1 reference

12 December 2020

Peroxyl radical scavenging activity of Ginkgo biloba extract EGb 761.

1 reference

12 December 2020

Ginkgolides, diterpene trilactones of Ginkgo biloba, as antagonists at recombinant alpha1beta2gamma2L GABAA receptors

1 reference

12 December 2020

An open-label pilot study of cannabis-based extracts for bladder dysfunction in advanced multiple sclerosis

1 reference

12 December 2020

Current Complementary and Alternative Therapies for Multiple Sclerosis

1 reference

12 December 2020

1,25-dihydroxyvitamin D3 treatment decreases macrophage accumulation in the CNS of mice with experimental autoimmune encephalomyelitis

1 reference

12 December 2020

The role of oxidative stress in the pathogenesis of multiple sclerosis: the need for effective antioxidant therapy

1 reference

12 December 2020

Cerebrospinal fluid levels of alpha-tocopherol in patients with multiple sclerosis

1 reference

12 December 2020

Vitamin D: a natural inhibitor of multiple sclerosis

1 reference

12 December 2020

The use of complementary and alternative therapies by people with multiple sclerosis

1 reference

12 December 2020

Predictors of alternative medicine use by multiple sclerosis patients

1 reference

12 December 2020

Omega-3 fatty acids and inflammation

1 reference

12 December 2020

Long-term exercise improves functional impairment but not quality of life in multiple sclerosis.

1 reference

12 December 2020

Effect of dietary advice and n-3 supplementation in newly diagnosed MS patients.

1 reference

12 December 2020

Increased plasma homocysteine levels without signs of vitamin B12 deficiency in patients with multiple sclerosis assessed by blood and cerebrospinal fluid homocysteine and methylmalonic acid.

1 reference

12 December 2020

10.1007/S11910-006-0014-Y

Identifiers

DOI

1 reference

14 August 2017

1 reference

PubMed ID

16635436